RSC Medicinal Chemistry

Article	Citations
Put a ring on it: application of small aliphatic rings in medicinal chemistry	219
Macrocyclization strategies for cyclic peptides and peptidomimetics	102
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis	102
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors	71
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates	69
Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies	66
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics	65
Recent developments on MOF-based platforms for antibacterial therapy	62
Target 2035 – update on the quest for a probe for every protein	54
Fragment-based drug discovery: opportunities for organic synthesis	43
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors	42
Recent advances in the development of covalent inhibitors	42
A review of the latest research on Mpro targeting SARS-COV inhibitors	39
Ruthenium(ii)–arene complexes as anti-metastatic agents, and related techniques	39
Polarity-based fluorescence probes: properties and applications	34
Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase	34
Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies	34
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch	33
The era of high-quality chemical probes	33
Aloe-emodin derived azoles as a new structural type of potential antibacterial agents: design, synthesis, and evaluation of the action on membrane, DNA, and MRSA DNA isomerase	32
Human carboxylesterases and fluorescent probes to image their activity in live cells	28
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers	27
Covalent PROTACs: the best of both worlds?	27
Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides	27
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors	27

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics	26
Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives	26
Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?	26
Siderophore conjugates to combat antibiotic-resistant bacteria	25
Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activity	25
Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots	25
Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs	22
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles	22
Recent advances in the development of AHR antagonists in immuno-oncology	21
Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses	21
Physicochemical properties and Mycobacterium tuberculosis transporters: keys to efficacious antitubercular drugs?	20
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations	20
Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents	20
Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020	20
Covalent drugs targeting histidine – an unexploited opportunity?	20
Oxazolidinones as versatile scaffolds in medicinal chemistry	20
Structure guided generation of thieno[3,2-d]pyrimidin-4-amine Mycobacterium tuberculosis bd oxidase inhibitors	20
Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents	20
Nitriles: an attractive approach to the development of covalent inhibitors	19
Chemical modulation of Kv7 potassium channels	19
Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis	19
Design, synthesis, and antibacterial activity ofN-(trifluoromethyl)phenyl substituted pyrazole derivatives	19
Antibacterial activities of plant-derived xanthones	18
Recent advances in synthetic and medicinal chemistry of phosphotyrosine and phosphonate-based phosphotyrosine analogues	18
Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold	18
Current leishmaniasis drug discovery	18
The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria	18
Selective degradation-inducing probes for studying cereblon (CRBN) biology	18
Natural product-informed exploration of chemical space to enable bioactive molecular discovery	18
Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies	16
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore model	16
Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA	16
PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery	16
Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activity	16
Natural-product-based fluorescent probes: recent advances and applications	16
Medicinal chemistry of the myeloid C-type lectin receptors Mincle, Langerin, and DC-SIGN	16
Current status and prospects of MIL-based MOF materials for biomedicine applications	16
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks	15
Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation	15
In vitroandin vivosigma 1 receptor imaging studies in different disease states	15
Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA	15
Activity-based protein profiling reveals deubiquitinase and aldehyde dehydrogenase targets of a cyanopyrrolidine probe	15
VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses	15
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling	15
A story of peptides, lipophilicity and chromatography – back and forth in time	15
Analysis of physicochemical properties of protein–protein interaction modulators suggests stronger alignment with the “rule of five”	14
Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-a]pyridine analogues	14
Deglycase-activity oriented screening to identify DJ-1 inhibitors	14
Amyloid inhibition by molecular chaperones in vitro can be translated to Alzheimer's pathology in vivo	14
Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors	14

Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents	14
Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer	14
Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives	13
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases	13
A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras	13
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators	13
Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity	13
Comprehensive analysis of commercial fragment libraries	13
CDK9 inhibitors in cancer research	13
Mechanisms and inhibitors of nicotinamide N-methyltransferase	13
Investigating 3,3-diaryloxetanes as potential bioisosteres through matched molecular pair analysis	13
The modulatory role of sulfated and non-sulfated small molecule heparan sulfate-glycomimetics in endothelial dysfunction: absolute structural clarification, molecular docking and simulated dynamics, S	13
Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes	13
Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studies	13
Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism	13
Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives	12
Bifunctional chelators for radiorhenium: past, present and future outlook	12
Profiling MAP kinase cysteines for targeted covalent inhibitor design	12
Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions	12
Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatus	12
Monobodies as tool biologics for accelerating target validation and druggable site discovery	12
An overview of the development of EED inhibitors to disable the PRC2 function	12
Proline pre-conditioning of cell monolayers increases post-thaw recovery and viability by distinct mechanisms to other osmolytes	12
Peptide directed phthalocyanine–gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancers	12
Pretargeted imaging beyond the blood–brain barrier	12
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors	12
Phthalimide analogs for antimalarial drug discovery	12
Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties	11
Ribosome-targeting antibiotics and resistance via ribosomal RNA methylation	11
Cyclisation strategies for stabilising peptides with irregular conformations	11
SF5- and SCF3-substituted tetrahydroquinoline compounds as potent bactericidal agents against multidrug-resistant persister Gram-positive bacteria	11
Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease	11
Inhibition of NaV1.7: the possibility of ideal analgesics	11
Antibacterial activities of anthraquinones: structure–activity relationships and action mechanisms	11
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties	11
Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors	11
De novo molecular drug design benchmarking	11
The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification	11
Amino alcohol acrylonitriles as broad spectrum and tumour selective cytotoxic agents	11
Red light active Pt(iv)–BODIPY prodrug as a mitochondria and endoplasmic reticulum targeted chemo-PDT agent	11
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders	10
N-1,2,3-Triazole–isatin derivatives: anti-proliferation effects and target identification in solid tumour cell lines	10
Cucurbit[8]uril-based supramolecular hydrogels for biomedical applications	10
It takes two to tango: synthesis of cytotoxic quinones containing two redox active centers with potential antitumor activity	10
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1	10
Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs	10
Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets	10
Estimating the cooperativity of PROTAC-induced ternary complexes using 19F NMR displacement assay	10
Replacement of oxygen with sulfur on the furanose ring of cyclic dinucleotides enhances the immunostimulatory effect via STING activation	10
Synthesis and immunological evaluation ofN-acyl modified Globo H derivatives as anticancer vaccine candidates	10
Molecular dynamics: a powerful tool for studying the medicinal chemistry of ion channel modulators	10
Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance	10
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators	9
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set	9
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms	9
Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model	9
Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorp	9
Covalent sortase A inhibitor ML346 prevents Staphylococcus aureus infection of Galleria mellonella	9
Identification of molecular glues of the SLP76/14-3-3 protein–protein interaction	9
Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint	9
Integrating a covalent probe with ubiquicidin fragment enables effective bacterial infection imaging	9
N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa	9
Targeting the protease of West Nile virus	9
Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram	9
NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody	9
4-Amino-1,8-naphthalimide–ferrocene conjugates as potential multi-targeted anticancer and fluorescent cellular imaging agents	9
Will the chemical probes please stand up?	9
Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins	9
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives	9
Silver N-heterocyclic carbene complexes are potent uncompetitive inhibitors of the papain-like protease with antiviral activity against SARS-CoV-2	9
Advanced approaches of developing targeted covalent drugs	9
Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer	8
Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents	8
Using membrane perturbing small molecules to target chronic persistent infections	8
Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia	8
The role of small molecules in cell and gene therapy	8
Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities	8
Stabilized cyclic peptides as modulators of protein–protein interactions: promising strategies and biological evaluation	8
Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy	8
Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach	8

Piperazine tethered bergenin heterocyclic hybrids: design, synthesis, anticancer activity, and molecular docking studies	8
New perspectives in cancer drug development: computational advances with an eye to design	8
Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain	8
Recent applications of covalent chemistries in protein–protein interaction inhibitors	8
A niclosamide–tobramycin hybrid adjuvant potentiates cefiderocol againstP. aeruginosa	8
Assessment of the rules related to gaining activity against Gram-negative bacteria	8
A second generation of 1,2,4-oxadiazole derivatives with enhanced solubility for inhibition of 3-hydroxykynurenine transaminase (HKT) from Aedes aegypti	8
Structure–activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors	8
Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking	8
An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases	8
Expanding the scope of novel 1,2,3-triazole derivatives as new antiparasitic drug candidates	7
Identification of the first structurally validated covalent ligands of the small GTPase RAB27A	7
Revisiting a challenging p53 binding site: a diversity-optimized HEFLib reveals diverse binding modes in T-p53C-Y220C	7
Structure–activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agents	7
SAR study of 4-arylazo-3,5-diamino-1H-pyrazoles: identification of small molecules that induce dispersal of Pseudomonas aeruginosa biofilms	7
Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents	7
Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis	7
Targeted protein degradation using the lysosomal pathway	7
Synthesis and bioactive evaluation of N-((1-methyl-1H-indol-3-yl)methyl)-N-(3,4,5-trimethoxyphenyl)acetamide derivatives as agents for inhibiting tubulin polymerization	7
Development of thiazole-appended novel hydrazones as a new class of α-amylase inhibitors with anticancer assets: anin silicoandin vitroapproach	7
Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands	7
Assessing the mechanisms of action of natural molecules/extracts for phase-directed wound healing in hydrogel scaffolds	7
Rational design of selective inhibitors of PARP4	7
Tackling antimicrobial stewardship through synergy and antimicrobial peptides	7
New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells	7
Current status of Fe-based MOFs in biomedical applications	7
Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy	7
Research status of indole-modified natural products	7
Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors	7
Synthesis and structure–activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine	7
Pharmacological overview of hederagenin and its derivatives	6
Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leads	6
Efficient selective targeting of Candida CYP51 by oxadiazole derivatives designed from plant cuminaldehyde	6
The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery	6
Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy	6
Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials	6
Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance	6
Evaluation of the effect of a cell penetrating peptide (TAT) towards tailoring the targeting efficacy and tumor uptake of porphyrin	6
Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6	6
Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents	6
A scaffold hopping strategy to generate new aryl-2-amino pyrimidine MRSA biofilm inhibitors	6
Novel irreversible peptidic inhibitors of transglutaminase 2	6
AiZynth impact on medicinal chemistry practice at AstraZeneca	6
Progress in mechanistically novel treatments for schizophrenia	6
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screening	6
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies	6
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood–brain barrier permeability	6
Therapeutic significance of molecular hybrids for breast cancer research and treatment	6
Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice	6
Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors	6
Synthesis and biological evaluation of a monocyclic Fc-binding antibody-recruiting molecule for cancer immunotherapy	6
Antiproliferative activity and toxicity evaluation of 1,2,3-triazole and 4-methyl coumarin hybrids in the MCF7 breast cancer cell line	6
Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity	6
The identification of highly efficacious functionalised tetrahydrocyclopenta[c]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly	6
Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155)	6
Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies	6
Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as TRK inhibitors	6
Small molecule-mediated induction of endoplasmic reticulum stress in cancer cells	6
Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and	5
The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors	5
A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation risk	5
Design, synthesis, and biological evaluation of 3,3′-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity	5
Designed hybrid anticancer nuclear-localized peptide inhibits aggressive cancer cell proliferation	5
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds	5
Design, synthesis and biological evaluation of light-driven on–off multitarget AChE and MAO-B inhibitors	5
Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants	5
On the origins of SARS-CoV-2 main protease inhibitors	5
X-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis	5
Introducing the metacore concept for multi-target ligand design	5
Synthesis of tryptanthrin appended dispiropyrrolidine oxindoles and their antibacterial evaluation	5
Synthesis and evaluation of pyridine-derived bedaquiline analogues containing modifications at the A-ring subunit	5
Enabling synthesis in fragment-based drug discovery (FBDD): microscale high-throughput optimisation of the medicinal chemist's toolbox reactions	5
First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators	5
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor	5
2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-N-oxide: the case of quorum sensing inhibitors	5
Antileishmanial evaluation of triazole–butenolide conjugates: design, synthesis, in vitro screening, SAR and in silico ADME predictions	5
Host–guest binding of tetracationic cyclophanes to photodynamic agents inhibits posttreatment phototoxicity and maintains antitumour efficacy	5
Reactive fragments targeting carboxylate residues employing direct to biology, high-throughput chemistry	5
Development of 2-deoxystreptamine–nucleobase conjugates for the inhibition of oncogenic miRNA production	5
Polysucrose hydrogel loaded with natural molecules/extracts for multiphase-directed sustainable wound healing	5
Synthesis of bis-furyl-pyrrolo[3,4-b]pyridin-5-ones via Ugi–Zhu reaction and in vitro activity assays against human SARS-CoV-2 and in silico studies on its main proteins	5
Introduction to the themed collection on fragment-based drug discovery	4
Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors	4
ItaCORMs: conjugation with a CO-releasing unit greatly enhances the anti-inflammatory activity of itaconates	4
Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D2 synthase	4
Using NMR to identify binding regions for N and C-terminal Hsp90 inhibitors using Hsp90 domains	4
Exploration of cytotoxic potential and tubulin polymerization inhibition activity of cis-stilbene-1,2,3-triazole congeners	4
Photochemical synthesis of an epigenetic focused tetrahydroquinoline library	4
Biological evaluation of novel amidino substituted coumarin-benzazole hybrids as promising therapeutic agents	4
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy	4
Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive group	4
Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer	4
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators	4
Unusual Ni⋯Ni interaction in Ni(ii) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs	4
Synthesis and biological evaluation of N6 derivatives of 8-azapurine as novel antiplatelet agents	4